Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor

NCT04810091 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Neuroendocrine Neoplasm
Metastatic Neuroendocrine Neoplasm

Interventions

DRUG: Placebo Administration
OTHER: Questionnaire Administration
DRUG: Telotristat Ethyl

Sponsor

M.D. Anderson Cancer Center